| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |